Gilla Signs Cannabis Licensing Agreement in

New Post Public Reply Private Reply Replies (0) Message Board
stockseekerok
197
Gilla Signs Cannabis Licensing Agreement in Nevada

TORONTO, ONTARIO--(Marketwired - Jun 20, 2017) - Gilla Inc. ("Gilla" or the "Company" (OTCQB:GLLA), the fast-growing designer, marketer and manufacturer of E-liquid for vaporizers and developer of cannabis concentrate products, today announced that the Company's Toronto-based subsidiary, Gilla Enterprises Inc., has entered into its first production and distribution licensing agreement (the "Licensing Agreement" to introduce and launch the Company's new portfolio of cannabis concentrate products. The Licensing Agreement has been entered into with Alternative Medicine Association, LC ("AMA" or the "Licensee", a Nevada-licensed medical marijuana establishment ("MME" which was recently acquired by Friday Night Inc. (CSE:TGIF), a Canadian-based public company.

Under the terms of the Licensing Agreement, the Company granted to the Licensee an exclusive five-year license to produce and distribute Gilla's unique array of cannabis concentrate products including its high terpene vape oils, naturally extracted vape oils and pure crystalline or high grade, naturally extracted cannabis crystals (together, the "Licensed Products" in the State of Nevada. The Licensee will manufacture the Licensed Products in its medical marijuana cultivation and production facility located in Las Vegas, Nevada for wholesale distribution utilizing Gilla's standard operating procedures, marketing support and brand name that will be announced and formally launched in the coming weeks. The Licensed Products are scheduled to be launched for sale on or around July 1, 2017 in conjunction with the adoption of recreational marijuana by the State of Nevada. As consideration for the license and rights granted under the Licensing Agreement, the Company will receive a fifteen percent royalty of gross revenues generated by the Licensed Products.

"This is a significant milestone for Gilla and we are very excited for the opportunity to work with our new partner to launch our newly developed portfolio of cannabis products alongside the adoption of recreational marijuana in Nevada," stated Mr. Graham Simmonds, Chairman and CEO of Gilla. He added, "AMA was the first-licensed MME in southern Nevada and operates a premier facility in the Las Vegas area. Their expertise and cultivation capacity has positioned them to become an industry leader in the wholesale marijuana business. In furthering our multi-jurisdictional mandate, the Company is working on a number of additional licensing opportunities in both the United States and Canada to bring Gilla's branded cannabis products to additional jurisdictions this year."

Mr. Mark Zobrist, CEO of AMA stated, "This is an excellent opportunity for Friday Night to broaden its product offering in preparation for the upcoming implementation of recreational marijuana in the State of Nevada." He added, "Our team is very impressed with the quality of the Gilla product offering and we look forward to a mutually-successful business relationship."

About Alternative Medicine Association, LC and Friday Night Inc.

Alternative Medicine Association, LC owns and operates a licensed medical marijuana cultivation and production facility in Las Vegas, Nevada. The company produces its own line of cannabis-based extracts including shatter, live resin, wax and oils including vape oils, flavored vape oils, terpene enhanced oils, and clear distillates and manufactures other third-party brands of similar products. Friday Night Inc., a Canadian public company (CSE:TGIF), recently acquired AMA and now owns or controls both hemp and cannabis based operations in the State of Nevada with plans to expand both within and outside of the state.

About Gilla Inc.

Gilla Inc. manufactures, markets and distributes E-liquid for use in vaporizers and develops turn-key vapor and cannabis concentrate solutions for high terpene vape oils, pure crystalline, high performance vape pens and other targeted products. Gilla aims to be a global leader in delivering the most efficient and effective vaping solutions for nicotine and cannabis related products. The Company's multi-jurisdictional, broad portfolio approach services both the nicotine and cannabis markets with high quality products that deliver a consistent and reliable user experience. Gilla's proprietary product portfolio includes the following brands: Coil Glaze™, Siren, The Drip Factory, Craft Vapes™, Craft Clouds, Surf Sauce, Vinto Vape, VaporLiq, Vape Warriors, Vapor's Dozen, Miss Pennysworth's Elixirs, The Mad Alchemist™, Replicant, Enriched Vapor and Crown E-liquid™.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ardelyx Securities Fraud Suit: Key Investor Moves

Updated Category News Views 5

Fraud Allegations: Ardelyx Under the Microscope Looks like Ardelyx has found itself neck-deep in trouble, facing a class action lawsuit over alleged securities fraud. This isn't just a storm in a teacup. We're talking about accusations of false and misleading statements tied to their commercial performance—statements that might have left investors holding the bag with...

Continue Reading
PrideStaff: 8 Years Strong on Franchise Times Top 400

Updated Category News Views 4

Where PrideStaff Stands in the Franchise Landscape Here's something the staffing world can't ignore: PrideStaff nailed it again, landing among the giants on the Franchise Times Top 400 for the eighth straight year. Sitting at number 217, this ain't just a lucky streak—this is a sustained homerun, my friends. Consistency Is Key, And They're Holding It Consider this...

Continue Reading
Steel Dynamics Gears Up for Q3 2026 Earnings Update

Updated Category News Views 6

Steel Dynamics Preps for Key Earnings Report Folks, we're staring down the barrel of another quarterly earnings report from Steel Dynamics, Inc., and you can bet this one is gonna have plenty of eyes glued. October 19th, 2026, that's when they'll peel back the curtain on how they fared in Q3. Now, buckle up, because this isn't just a numbers game—it’s a snapshot of...

Continue Reading
Newfold Digital Revamps Leadership for Growth Surge

Updated Category News Views 4

Steering into New Horizons with Fresh Leadership October 2026 marks a fresh chapter for Newfold Digital, as they shuffle the deck chairs a bit and ramp up for some ambitious growth endeavors. This web and commerce tech company decided it's time to bring a few heavy hitters on board. Starting this month, watch out for Sachin Puri taking the reins as Chief Executive...

Continue Reading
CME Group Unveils First Baseball Futures Market

Updated Category News Views 6

A New Pitch in the Financial Ballpark Alright, listen up: CME Group is stepping up to the plate with a game-changer. They’re rolling out the world’s first baseball futures, launching October 12, assuming regulators give the green light. Now, this isn’t just some novelty act; it’s based on the solid groundwork of their FutureSports Performance Indexes (CME FSPI),...

Continue Reading
Hexaware Teams with Anthropic for Game-Changing AI Move

Updated Category News Views 4

A Bold AI Partnership on the Horizon Mutual back-slapping or a deal with authentic grit? Hexaware’s latest tango with Anthropic might just be the jolt enterprises need. Announced under the flickering fluorescent lights of Mumbai, London, and Iselin, Hexaware’s multi-year partnership with Anthropic thrusts Claude, their razor-sharp AI, right into the mix of...

Continue Reading
Protecting Your Family on Halloween: Safety Tips

Updated Category News Views 5

Avoid Turning Halloween Fun Into a Medical Emergency Halloween should be about ghosts and ghouls, not a dreaded detour to the ER. Yet, every year, adults and kids get carried away with costumes, only to find themselves in a real-life horror show courtesy of a slip, a fall, or a carving mishap. The American Academy of Orthopaedic Surgeons (AAOS) is waving the safety flag,...

Continue Reading
Lupin Secures FDA Nod for Key Injectable Drug

Updated Category News Views 4

Lupin's FDA Approval: A Strategic Play in Pharmaceuticals Ah, the thrill of a new approval! Lupin Limited has landed U.S. FDA approval for their Phytonadione Injectable Emulsion, marking a significant stride into the lucrative realm of vitamin K treatments. This approval isn't just a feather in Lupin's cap—it's a calculated move to corner a piece of the estimated $52.3...

Continue Reading
Webull Faces Legal Scrutiny Over Chinese Ties

Updated Category News Views 4

The Unfolding Drama for Webull Shareholders When you see a ticker like NASDAQ:BULL rolling off your tongue these days, it’s not just about stock prices anymore—it's a whole saga wrapped in legal and geopolitical spice. Following the recent uproar from a House China committee report, Webull found itself thrust into the spotlight for all the wrong reasons. That report...

Continue Reading
Striveworks: Boosting Army's AI Edge in Indo-Pacific

Updated Category News Views 6

The world keeps marching forward, and here’s Striveworks stepping up to the plate with another big move in the military tech space. This isn't your average partnership renewal; this involves a five-year, $200 million deal to enhance battlefield AI as the U.S. Army hones its modern warfare edge in the Indo-Pacific. Now, this isn't just a battle of strategies but a battle...

Continue Reading

Top 5 Most Recently Viewed Articles

Medpace Holdings Achieves Impressive Revenue Growth Despite Challenges

Updated Category News Views 187

Medpace Holdings Reports Strong Financial Growth Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent provider of clinical research services, has recently demonstrated impressive financial performance with an 8.3% revenue increase year-over-year, totaling $533.3 million in the third quarter. Net income also surged by 36.7%, reaching $96.4 million. This positive growth comes...

Continue Reading
ECARX Launches Ambitious $20M Share Buyback Initiative

Updated Category News Views 118

ECARX Unveils $20 Million Share Repurchase Plan ECARX Holdings, Inc. (Nasdaq: ECX) is taking a significant step in its financial strategy by launching a share repurchase program valued at up to $20 million. This development indicates the company's commitment to returning value to shareholders while optimizing its capital structure. Details of the Share Repurchase Program...

Continue Reading
Abpro Holdings Marks Major Milestone with Successful IPO Ceremony

Updated Category News Views 163

Abpro Holdings Celebrates Its Successful Business Combination Abpro Holdings, Inc. (Nasdaq:ABP) is excited to announce the completion of its business combination with Atlantic Coastal Acquisition Corp II. A grand bell ringing ceremony at Nasdaq marked this significant achievement, highlighting the dedication and hard work Abpro has put into this journey. Through this...

Continue Reading
Navigating Securities Losses: A Look at Compass Diversified

Updated Category News Views 169

Understanding Your Rights as an Investor Investors in Compass Diversified Holdings (NYSE: CODI) facing substantial losses have a critical opportunity to take action. Many investors find themselves in challenging positions when companies fail to disclose critical financial information. Such scenarios can lead to significant investment losses. Understanding one's rights and...

Continue Reading
Exploring Future Growth in the Blood Glucose Monitoring Market

Updated Category News Views 247

The Rising Demand for Blood Glucose Monitoring Devices As health awareness increases and diabetes continues to affect millions globally, the Blood Glucose Monitoring Device market is set to experience remarkable expansion. Valued at USD 13.49 billion in recent times, this industry is anticipated to grow significantly, reaching around USD 27.61 billion by 2032. This...

Continue Reading